COMMUNIQUÉS West-GlobeNewswire

Codexis Appoints Christos Richards to Board of Directors
16/01/2025
REDWOOD CITY, Calif., Jan. 16, 2025 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ: CDXS), a leading provider of enzymatic solutions for efficient and scalable therapeutics manufacturing, today announced the appointment of [...]
Scorpius Holdings Announces Reverse Stock Split
16/01/2025
DURHAM, N.C., Jan. 16, 2025 (GLOBE NEWSWIRE) -- Scorpius Holdings, Inc (NYSE American: SCPX) (“Scorpius” or “the Company”), an integrated contract development and manufacturing organization (“CDMO”), today announced [...]
Scilex Holding Company Amends its License Agreement with Romeg Therapeutics, LLC, For the Worldwide Rights to Commercialize Gloperba®, an FDA-Approved Prophylactic Treatment for Painful Gout Flares in Adults
16/01/2025
Gloperba® is the first and only liquid oral version of the anti-gout medicine colchicine indicated for the prophylaxis of painful gout flares in adults. Over 70% of gout patients have comorbid conditions that may [...]
Aledade Launches Policy Institute to Shape Value-Based Care Transformation
16/01/2025
Policy Institute to convene national experts and inform policies that strengthen primary care and drive value-based care adoption nationwide BETHESDA, Md., Jan. 16, 2025 (GLOBE NEWSWIRE) -- To strengthen primary care [...]
Vaxil Bio Proposed Reverse Takeover With Green Date Terminated
16/01/2025
Not for distribution to United States newswire services or for release publication, distribution or dissemination directly, or indirectly, in whole or in part, in or into the United States NESS-ZIONA, Israel, Jan. 16, [...]
Virbac: Strong annual revenue growth of +13.6% supported by dynamic organic growth (+7.5%) and the strategic contribution of our acquisitions (+6.1%)
16/01/2025
Strong annual revenue growth of +13.6% supported by dynamic organic growth (+7.5%) and the strategic contribution of our acquisitions (+6.1%) Press release issued on January 16, 2025 after market close at 5:45pm CET KEY [...]
VIRBAC: Forte progression du chiffre d'affaires : +13.6% sur l'année, soutenue par une croissance organique dynamique (+7.5%) et l'apport stratégique de nos acquisitions (+6.1%)
16/01/2025
Forte progression du chiffre d'affaires : +13.6% sur l'année, soutenue par une croissance organique dynamique (+7.5%) et l'apport stratégique de nos acquisitions (+6.1%) Communiqué diffusé le 16 janvier 2025 après [...]
USOSM Enters 2025 Strong, Announces New Partner Practice in South Carolina
16/01/2025
IRVING, Texas, Jan. 16, 2025 (GLOBE NEWSWIRE) -- U.S. Oral Surgery Management ( USOSM) – a management services company that exclusively serves premier oral and maxillofacial surgeons – has formed a new partnership with [...]
Boehringer provides update on iclepertin Phase III program in schizophrenia
16/01/2025
Boehringer Ingelheim today announced top-line results from the Phase III CONNEX clinical program in cognitive impairment in adults with schizophrenia, showing primary and key secondary endpoints were not met. 1–6 [...]
Lung Health Foundation Announces New Leaders to Reshape Lung Healthcare in Canada
16/01/2025
TORONTO, Jan. 16, 2025 (GLOBE NEWSWIRE) -- The Lung Health Foundation (LHF) is poised to reshape the future of lung healthcare in Canada with the appointment of three dynamic leaders to tackle an escalating public [...]
Total Ancillary Launches Healthview360™
16/01/2025
Wound Care Management SaaS Platform is First of its Kind DALLAS, Jan. 16, 2025 (GLOBE NEWSWIRE) -- Wound care management innovator Total Ancillary announces the full market launch of Healthview360™, an advanced SaaS ( [...]
King Faisal Specialist Hospital and Research Centre Performs the World's First Robotic-Assisted Artificial Heart Pump Implantation
16/01/2025
RIYADH, Saudi Arabia, Jan. 16, 2025 (GLOBE NEWSWIRE) -- King Faisal Specialist Hospital and Research Centre (KFSHRC) in Riyadh has successfully performed the world’s first robotic-assisted implantation of an artificial [...]
Progyny Appoints Healthcare Veteran Debra Morris to Board of Directors
16/01/2025
NEW YORK, Jan. 16, 2025 (GLOBE NEWSWIRE) -- Progyny, Inc. (Nasdaq: PGNY), a transformative fertility, family building and women’s health benefits solution, today announced the appointment of 30-year healthcare industry [...]
Autoimmunity BioSolutions to Present at the 2025 Sequire Investor Summit in Puerto Rico
16/01/2025
Houston, Texas, Jan. 16, 2025 (GLOBE NEWSWIRE) -- Autoimmunity BioSolutions is proud to announce that it will be presenting at the upcoming Sequire Investor Summit 2025. The 2025 Edition of the Sequire Investor Summit [...]
PeopleOne Health Appoints Ty Arlint as Chief Revenue Officer
16/01/2025
Seasoned healthcare executive to spearhead growth strategies and market expansion as PeopleOne Health brings its innovative value-based care model to more regions PITTSBURGH, Jan. 16, 2025 (GLOBE NEWSWIRE) -- PeopleOne [...]
Metagenomi Highlights Progress Across Therapeutic Portfolio and Outlines Anticipated Milestones
16/01/2025
MGX-001 in Hemophilia A Advances Towards US and Ex-US Regulatory Interactions in 2025 NHP Proof-of-Concept Anticipated for Secreted Protein Deficiency Platform in 2025 Leveraging MGX-001 Editing Approach On Track for [...]
Femasys Announces Notice of Allowance for New U.S. Patent Application Covering Use of FemaSeed® for Female Infertility Treatment
16/01/2025
FemaSeed ® patent application provides additional coverage for Femasys’ therapeutic option for women seeking infertility solution ATLANTA, Jan. 16, 2025 (GLOBE NEWSWIRE) -- Femasys, Inc., (Nasdaq: FEMY), a leading [...]
FOXO TECHNOLOGIES INC., CONFIRMS DETAILS OF SPECIAL MEETING OF SHAREHOLDERS ON JANUARY 17, 2025.
16/01/2025
MINNEAPOLIS, MN, Jan. 16, 2025 (GLOBE NEWSWIRE) -- FOXO Technologies Inc. (NYSE American: FOXO) (the “Company” or “FOXO”), will hold its previously announced Special Meeting of its Shareholders at 10:30 am EST on Friday [...]
United Arab Emirates Ministry of Health and Prevention Approves Biomerica’s Fortel® PSA Screening Test to Detect an Early Sign of Prostate Cancer
16/01/2025
- 10-Minute PSA Test for Early Detection of Prostate Specific Antigen (PSA), an Early Warning Sign of Prostate Cancer - Prostate Cancer: The Second Most Common Cancer in Men Globally IRVINE, Calif., Jan. 16, 2025 (GLOBE [...]

Pages